These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15542280)

  • 1. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides.
    Foote RS; Pearlman JD; Siegel AH; Yeo KT
    J Am Coll Cardiol; 2004 Nov; 44(10):1980-7. PubMed ID: 15542280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia.
    Sabatine MS; Morrow DA; de Lemos JA; Omland T; Desai MY; Tanasijevic M; Hall C; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2004 Nov; 44(10):1988-95. PubMed ID: 15542281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of changes in B-type natriuretic peptides to detect ischemia in selected patients.
    Staub D; Jauslin D; Freidank H; Taegtmeyer A; Breidthardt T; Zellweger MJ; Mueller-Brand J; Christ M; Mueller C
    Int J Cardiol; 2009 Jul; 136(1):40-6. PubMed ID: 18632168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of absolute and relative exercise-induced changes in B-type natriuretic peptides.
    Maeder MT; Staub D; Surnier Y; Reichlin T; Noveanu M; Breidthardt T; Potocki M; Schaub N; Conen D; Mueller C
    Int J Cardiol; 2011 Mar; 147(3):409-15. PubMed ID: 19897258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of serum B-type natriuretic peptide for myocardial ischemia detection during exercise testing with spect perfusion imaging.
    Zaid G; Tanchilevitch A; Rivlin E; Gropper R; Rosenschein U; Lanir A; Goldhammer E
    Int J Cardiol; 2007 Apr; 117(2):157-64. PubMed ID: 16997398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia.
    Staub D; Jonas N; Zellweger MJ; Nusbaumer C; Wild D; Pfisterer ME; Mueller-Brand J; Perruchoud AP; Mueller C
    Am J Med; 2005 Nov; 118(11):1287. PubMed ID: 16271916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
    Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
    Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of stress-induced reversible ischemia on serum concentrations of ischemia-modified albumin, natriuretic peptides and placental growth factor.
    Kurz K; Voelker R; Zdunek D; Wergeland R; Hess G; Ivandic B; Katus H; Giannitsis E
    Clin Res Cardiol; 2007 Mar; 96(3):152-9. PubMed ID: 17180576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of N-terminal pro-B-type natriuretic peptide increase with exercise for predicting cardiovascular mortality in patients with heart failure.
    Koç M; Bozkurt A; Acartürk E; Sahin DY; Unal I
    Am J Cardiol; 2008 Apr; 101(8):1157-62. PubMed ID: 18394451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of B-type natriuretic peptide in the detection of myocardial ischemia.
    Staub D; Nusbaumer C; Zellweger MJ; Jonas N; Wild D; Pfisterer ME; Mueller-Brand J; Perruchoud AP; Mueller C
    Am Heart J; 2006 Jun; 151(6):1223-30. PubMed ID: 16781223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal-proB natriuretic peptide in patients with stable coronary artery disease evaluated for ischemia with myocardial perfusion imaging.
    Majstorov V; Pop GD; Vavlukis M; Peovska I; Maksimovik J; Vaskova O; Kuzmanovska S; Zdraveska-Kochovska M
    Bratisl Lek Listy; 2008; 109(7):293-7. PubMed ID: 18792482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
    Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-brain natriuretic peptide predicts myocardial ischemia and is related to postischemic left-ventricular dysfunction in patients with stable coronary artery disease.
    Vanzetto G; Jacon P; Calizzano A; Neuder Y; Faure P; Fagret D; Machecourt J
    J Nucl Cardiol; 2007; 14(6):835-42. PubMed ID: 18022110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide and clinical judgment in the detection of exercise-induced myocardial ischemia.
    Lee G; Sou SM; Twerenbold R; Reichlin T; Oshima S; Hochgruber T; Zürcher S; Matter D; Tanglay Y; Freese M; Honegger U; Wild D; Rentsch K; Osswald S; Zellweger MJ; Mueller C
    Am J Med; 2014 May; 127(5):427-35. PubMed ID: 24486287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NT-Pro-BNP levels and their response to exercise in patients with slow coronary flow.
    Yurtdaş M; Ozcan IT; Camsar A; Ciçek D; Tamer L; Cin VG; Döven O; Seyis AS; Akkuş MN
    Arq Bras Cardiol; 2012 Dec; 99(6):1115-22. PubMed ID: 23152289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative value of BNP and NT-proBNP in diagnosis of heart failure.
    Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F
    Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of N-terminal pro-B-type natriuretic peptide levels to predict exercise capacity in hypertrophic cardiomyopathy.
    Thaman R; Esteban MT; Barnes S; Gimeno JR; Mist B; Murphy R; Collinson PO; McKenna WJ; Elliott PM
    Am J Cardiol; 2006 Aug; 98(4):515-9. PubMed ID: 16893708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NT-pro-BNP is associated with inducible myocardial ischemia in mildly symptomatic type 2 diabetic patients.
    Wiersma JJ; van der Zee PM; van Straalen JP; Fischer JC; van Eck-Smit BLF; Tijssen JGP; Trip MD; Piek JJ; Verberne HJ
    Int J Cardiol; 2010 Nov; 145(2):295-296. PubMed ID: 19900726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.